Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio

Insider Transactions by Young David

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
PCSAProcessa Pharmaceuticals, Inc.Young DavidPres. Research & DevelopmentJan 01, 2024Option Exercise$2.795181,44580,544Apr 12, 2024, 05:01 PM
PCSAProcessa Pharmaceuticals, Inc.Young DavidPres. Research & DevelopmentFeb 07, 2024Buy$2.4521,00051,52679,387Feb 08, 2024, 04:30 PM
PCSAProcessa Pharmaceuticals, Inc.Young DavidPres. Research & DevelopmentFeb 06, 2024Buy$2.5320,00050,50458,387Feb 07, 2024, 04:22 PM
PCSAProcessa Pharmaceuticals, Inc.Young DavidPres. Research & DevelopmentOct 12, 2023Option Exercise$0.29155,27745,030767,701Oct 12, 2023, 05:54 PM
PCSAProcessa Pharmaceuticals, Inc.Young DavidPres. Research & DevelopmentOct 10, 2023Option Exercise$0.24142,00034,080612,424Oct 10, 2023, 05:03 PM
PCSAProcessa Pharmaceuticals, Inc.Young DavidPresident & CEOJun 12, 2023Buy$0.8040,00032,000470,424Jun 12, 2023, 04:31 PM
PCSAProcessa Pharmaceuticals, Inc.Young DavidPresident & CEOApr 14, 2023Buy$0.5520,00010,998430,424Apr 14, 2023, 06:16 PM
PCSAProcessa Pharmaceuticals, Inc.Young DavidPresident & CEOApr 11, 2023Buy$0.5220,00010,400370,424Apr 13, 2023, 04:51 PM
PCSAProcessa Pharmaceuticals, Inc.Young DavidPresident & CEOApr 12, 2023Buy$0.4520,0009,000390,424Apr 13, 2023, 04:51 PM
PCSAProcessa Pharmaceuticals, Inc.Young DavidPresident & CEOApr 13, 2023Buy$0.4820,0009,600410,424Apr 13, 2023, 04:51 PM
PCSAProcessa Pharmaceuticals, Inc.Young DavidPresident & CEOFeb 09, 2023Option Exercise$0.8018,75015,000350,424Feb 10, 2023, 05:04 PM
PCSAProcessa Pharmaceuticals, Inc.Young DavidPresident & CEOAug 05, 2022Option Exercise$3.172,5318,023387,034Aug 09, 2022, 04:26 PM
PCSAProcessa Pharmaceuticals, Inc.Young DavidChief Executive OfficerJun 23, 2021Buy$7.6710,00076,716345,190Jun 23, 2021, 05:12 PM
QCORQUESTCOR PHARMACEUTICALS INCYoung DavidChief Scientific OfficerJun 24, 2014Option Exercise$48.2512,000579,004117,741Jun 26, 2014, 07:50 PM
QCORQUESTCOR PHARMACEUTICALS INCYoung DavidChief Scientific OfficerMar 14, 2014Sale$33.4112,000400,909117,741Mar 18, 2014, 04:05 PM
QCORQUESTCOR PHARMACEUTICALS INCYoung DavidChief Scientific OfficerMar 03, 2014Option Exercise$5.776,00034,620111,741Mar 05, 2014, 07:43 PM
QCORQUESTCOR PHARMACEUTICALS INCYoung DavidChief Scientific OfficerFeb 24, 2014Option Exercise$63.9129,1271,861,441111,351Feb 26, 2014, 08:03 PM
QCORQUESTCOR PHARMACEUTICALS INCYoung DavidChief Scientific OfficerJan 29, 2014Option Exercise$7.5420,000150,800111,145Jan 31, 2014, 08:19 PM
QCORQUESTCOR PHARMACEUTICALS INCYoung DavidChief Scientific OfficerJan 24, 2014Sale$34.4612,000413,53497,145Jan 28, 2014, 07:46 PM
QCORQUESTCOR PHARMACEUTICALS INCYoung DavidChief Scientific OfficerNov 19, 2013Option Exercise$5.7715,00086,55089,603Nov 21, 2013, 05:20 PM
QCORQUESTCOR PHARMACEUTICALS INCYoung DavidChief Scientific OfficerNov 13, 2013Sale$33.47200,0006,694,030174,603Nov 15, 2013, 07:10 PM
QCORQUESTCOR PHARMACEUTICALS INCYoung DavidChief Scientific OfficerAug 10, 2012Option Exercise$4.3610,62546,31913,903Aug 14, 2012, 03:58 PM
QCORQUESTCOR PHARMACEUTICALS INCYoung DavidChief Scientific OfficerApr 27, 2012Sale$23.68140,0003,314,50073,278May 01, 2012, 05:13 PM
QCORQUESTCOR PHARMACEUTICALS INCYoung DavidChief Scientific OfficerOct 31, 2011Sale$23.35154,7243,613,32483,002Nov 02, 2011, 04:41 PM
QCORQUESTCOR PHARMACEUTICALS INCYoung DavidChief Scientific OfficerAug 12, 2011Sale$16.9018,516312,95717,610Aug 16, 2011, 05:26 PM
QCORQUESTCOR PHARMACEUTICALS INCYoung DavidChief Scientific OfficerAug 15, 2011Sale$17.2011,884204,44314,094Aug 16, 2011, 05:26 PM
QCORQUESTCOR PHARMACEUTICALS INCYoung DavidChief Scientific OfficerAug 05, 2011Sale$15.0720,000301,40018,402Aug 09, 2011, 04:48 PM
QCORQUESTCOR PHARMACEUTICALS INCYoung DavidChief Scientific OfficerNov 02, 2010Sale$6.7356,250378,33536,422Nov 04, 2010, 09:16 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe